Laboratory and Genetic Assessment of Iron Deficiency in Blood Donors

Clinics in Laboratory Medicine

Volumn 35, Issue 1, 2015, Pages 73-91

  Kiss, Joseph E ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Blood donation; Ferritin; Hereditary hemochromatosis (HFE); Hypochromic mature red blood cells; Iron deficiency; Reticulocyte hemoglobin content; Soluble transferrin receptor; TMPRSS6

Indexed keywords

FERRITIN; PROTOPORPHYRIN ZINC; TRANSFERRIN; TRANSFERRIN RECEPTOR; IRON; PROTOPORPHYRIN;

BLOOD CELL COUNT; BLOOD DONOR; BLOOD OXYGEN TENSION; CELL MATURATION; ERYTHROCYTE DISORDER; FERRITIN BLOOD LEVEL; GENE FUNCTION; GENE MUTATION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC VARIABILITY; HEMOCHROMATOSIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON ABSORPTION; IRON BALANCE; IRON BINDING CAPACITY; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON DEPLETION; IRON METABOLISM; LABORATORY TEST; MEAN CORPUSCULAR VOLUME; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RETICULOCYTE HEMOGLOBIN CONTENT; REVIEW; ANEMIA, IRON-DEFICIENCY; BLOOD; BLOOD ANALYSIS; FEMALE; GENETICS; MALE; PROCEDURES;

ANEMIA, IRON-DEFICIENCY; BLOOD CHEMICAL ANALYSIS; BLOOD DONORS; FEMALE; HEMOCHROMATOSIS; HUMANS; IRON; MALE; PROTOPORPHYRINS;

EID: 84922380798     PISSN: 02722712     EISSN: 15579832     Source Type: Journal    
DOI: 10.1016/j.cll.2014.10.011     Document Type: Review

References (75)

1. Whitaker BI, Hinkins S. The 2011 National Blood Collection and Utilization Survey Report. The United States department of health and human services. Available at: . Accessed December 08, 2014. http://www.hhs.gov/ash/bloodsafety/2011-nbcus.pdf.
2. Finch C.A., Cook J.D., Labbe R.F., et al. Effect of blood donation on iron stores as evaluated by serum ferritin. Blood 1977, 50:441-447.
3. Simon T.L., Garry P.J., Hooper E.M. Iron stores in blood donors. JAMA 1981, 245:2038-2043.
4. Cable R.G., Glynn S.A., Kiss J.E., et al. Iron deficiency in blood donors: the REDS-II Donor Iron Status Evaluation (RISE) study. Transfusion 2011, 10.1111/j.1537-2995.2011.03401.x.
5. Jahanshad N., Kohannim O., Hibar D.P., et al. Brain structure in healthy adults is related to serum transferrin and the H63D polymorphism in the HFE gene. Proc Natl Acad Sci USA 2012, 109:e851-e859.
6. Krayenbuehl P.A., Battegay E., Breymann C., et al. Intravenous iron for the treatment of fatigue in nonanemic, premenopausal women with low serum ferritin concentration. Blood 2011, 118:3222-3227.
7. Brownlie T., Utermohlen V., Hinton P.S., et al. Tissue iron deficiency without anemia impairs adaptation in endurance capacity after aerobic training in previously untrained women. Am J Clin Nutr 2004, 79:437-443.
8. Murray-Kolb L.E., Beard J.L. Iron treatment normalizes cognitive functioning in young women. Am J Clin Nutr 2007, 85(3):778-787.
9. Bryant B.J., Yau Y.Y., Arceo S.M., et al. Ascertainment of iron deficiency and depletion in blood donors through screening questions for pica and restless leg syndrome. Transfusion 2013, 53:1637-1644.
10. Spencer B.R., Kleinman S., Wright D.J., et al. Restless legs syndrome, pica, and iron status in blood donors. Transfusion 2013, 53(8):1645-1652.
11. Hallberg L., Hulten L., Gramatkovski E. Iron absorption from the whole diet in men: how effective is the regulation of iron absorption?. Am J Clin Nutr 1997, 66:347-356.
12. Garry P.J., Koehler K.M., Simon T.L. Iron stores and iron absorption: effects of repeated blood donations. Am J Clin Nutr 1995, 62:611-620.
13. Cook J.D., Flowers C.H., Skikne B.S. The quantitative assessment of body iron. Blood 2003, 101(9):3359-3364.
14. Suominen P., Punnonen K., Rajamäki A., et al. Serum transferrin receptor and transferrin receptor ferritin index identify healthy subjects with subclinical iron deficits. Blood 1998, 92(8):2934-2939.
15. Worwood M. Serum transferrin receptor assays and their application. Ann Clin Biochem 2002, 39:221-230.
16. Ganz T., Nemeth E. Regulation of iron acquisition and iron distribution in mammals. Biochim Biophys Acta 2006, 1763:690-699.
17. Goodnough L.T., Nemeth E., Ganz T. Detection, evaluation, and management of iron-restricted erythropoiesis. Blood 2010, 116:4754-4761.
18. Thomas D.W., Hinchliffe R.F., Briggs C., British Committee for Standards in Haematology, et al. Guideline for the laboratory diagnosis of functional iron deficiency. Br J Haematol 2013, 161:639-648.
19. Farrugia A. Iron and blood donation - an under-recognized safety issue. Advances in Transfusion Safety - volume IV. Dev Biol 2007, 127:137-146.
20. Ferritin [Package Insert]. Advia centaur assay manual. 111353 Rev J, 2005-02. Bayer HealthCare LLC; 1998.
21. Cook J.D., Skikne B.S. Serum ferritin: a possible model for the assessment of nutrient stores. Am J Clin Nutr 1982, 35:S1180-S1185.
22. Cook J.D. Serum ferritin as a measure of iron stores in normal subjects. Am J Clin Nutr 1974, 27:681-687.
23. Punnonen K., Irjala K., Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron-deficiency anemia. Blood 1997, 89:1052-1057.
24. Hallberg L., Bengtsson C., Lapidus L., et al. Screening for iron deficiency: an analysis based on bone-marrow examinations and serum ferritin determinations in a population sample of women. Br J Haematol 1993, 85:787-798.
25. Guyatt G.H., Oxman A.D., Ali M., et al. Laboratory diagnosis of iron-deficiency anemia: an overview. JGen Intern Med 1992, 7:145-153.
26. Mast A.E., Blinder M.A., Gronowski A.M., et al. Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. Clin Chem 1998, 44(1):45-51.
27. Cable R.G., Glynn S.A., Kiss J.E., et al. Iron deficiency in blood donors: analysis of enrollment data from the REDS-II Donor Iron Status Evaluation (RISE) study. Transfusion 2011, 51:511-522.
28. Rosvik A.S., Ulvik R.J., Wentzel-Larsen T., et al. The effect of blood donation frequency on iron status. Transfus Apher Sci 2009, 41:165-169.
29. O'Meara A., Infanti L., Stebler C., et al. The value of routine ferritin measurement in blood donors. Transfusion 2011, 51:2183-2188.
30. Punnonen K., Rajamäki A. Evaluation of iron status of Finnish blood donors using serum transferrin receptor. Transfus Med 1999, 9:131-134.
31. Thorpe S.J., Heath A., Sharp G., et al. AWHO reference reagent for the Serum Transferrin Receptor (sTfR): international collaborative study to evaluate a recombinant transferrin receptor preparation. Clin Chem Lab Med 2010, 48:815-820.
32. Kiss J.E., Steele W.R., Wright D.J., et al. NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II). Laboratory variables for assessing iron deficiency in REDS-II Iron Status Evaluation (RISE) blood donors. Transfusion 2013, 2013(53):2766-2775.
33. Nadarajan V., Sthaneshwar P., Eow G.I. Use of red blood cell indices for the identification of Iron deficiency among blood donors. Transfus Med 2008, 18:184-189.
34. Radtke H., Meyer T., Kalus U., et al. Rapid identification of iron deficiency in blood donors with red cell indexes provided by Advia 120. Transfusion 2005, 45:5-10.
35. Semmelrock M.J., Raggam R.B., Amrein K., et al. Reticulocyte hemoglobin content allows early and reliable detection of functional iron deficiency in blood donors. Clin Chim Acta 2011, 10.1016/j.cca.2011.12.006.
36. Skikne B.S., Flowers C.H., Cook J.D. Serum transferrin receptor: a quantitative measure of tissue iron deficiency. Blood 1990, 75:1870-1876.
37. Kiss J.E., Cable R.G., Steele W.R., et al. Quantification of iron stores and iron absorption in REDS-II iron evaluation study (RISE) donors. Transfusion 2013, 53. S47-030G.
38. Labbe R.F., Vreman H.J., Stevenson D.K. Zinc protoporphyrin: a metabolite with a mission. Clin Chem 1999, 45:2060-2072.
39. Graham E.A., Felgenhauer J., Detter J.C., et al. Elevated zinc protoporphyrin associated with thalassemia trait and hemoglobin E. JPediatr 1996, 129:105-110.
40. Harthoorn-Lasthuizen E.J., Lindemans J., Langenhuijsen M.M. Zinc protoporphyrin as screening test in female blood donors. Clin Chem 1998, 44:800-804.
41. Baart A.M., deKort W.L., Moons K.G., et al. Zinc protoporphyrin levels have -added value in the prediction of low hemoglobin deferral in whole blood donors. Transfusion 2013, 53:1661-1669.
42. Baart A.M., deKort W.L., Moons K.G., et al. External validation and updating of a Dutch prediction model for low hemoglobin deferral in Irish whole blood donors. Transfusion 2013, 10.1111/trf.12211.
43. Gorlin J. Commentary: iron man pentathlon or "we have met the enemy and they is us!". Transfusion 2014, 54:747-749.
44. Alexander H.D., Sherlock J.P., Bharucha C. Red cell indices as predictors of iron depletion in blood donors. Clin Lab Haematol 2000, 22:253-258.
45. Stern M., O'Meara A., Infanti L., et al. Prognostic value of red blood cell parameters and ferritin in predicting deferral due to low hemoglobin in whole blood donors. Ann Hematol 2012, 91:775-780. 10.1007/s00277-011-1371-4.
46. Harris N., Kunicka J., Kratz A. The ADVIA 2120 hematology system: flow cytometry-based analysis of blood and body fluids in the routine hematology laboratory. Lab Hematol 2005, 11:47-61.
47. Thomas C., Thomas L. Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency. Clin Chem 2002, 48:1066-1076.
48. Kotisaari S., Romppanen J., Penttilä I., et al. The Advia 120 red blood cell and reticulocyte indices are useful in diagnosis of iron-deficiency anemia. Eur J Haematol 2002, 68:150-156.
49. Kotisaari S., Romppanen J., Agren U., et al. Reticulocyte indices rapidly reflect an increase in iron availability for erythropoiesis. Haematologica 2003, 88:1422-1423.
50. Ervasti M., Kotisaari S., Heinonen S., et al. Use of advanced red blood cell and reticulocyte indices improves the accuracy in diagnosing iron deficiency in pregnant women at term. Eur J Haematol 2007, 79:539-545. [Erratum in: Eur J Haematol 2008;80:92].
51. Buttarello M., Pajola R., Novello E., et al. Diagnosis of iron deficiency in patients undergoing hemodialysis. Am J Clin Pathol 2010, 133:949-954.
52. Brugnara C., Zurakowski D., DiCanzio J., et al. Reticulocyte hemoglobin content to diagnose iron deficiency in children. JAMA 1999, 281:2225-2230.
53. Brugnara C. Iron deficiency and erythropoiesis: new diagnostic approaches. Clin Chem 2003, 49(10):1573-1578.
54. Brugnara C., Laufer M.R., Friedman A.J., et al. Reticulocyte hemoglobin content (CHr): early indicator of iron deficiency and response to therapy. Blood 1994, 83(10):3100-3101.
55. Macdougall I.C., Cavill I., Hulme B., et al. Detection of functional iron deficiency during erythropoietin treatment: a new approach. BMJ 1992, 304:225-226.
56. Mast A.E., Blinder M.A., Lu Q., et al. Clinical utility of the reticulocyte hemoglobin content in the diagnosis of iron deficiency. Blood 2002, 99:1489-1491.
57. Bovy C., Gothot A., Delanaye P., et al. Mature erythrocyte parameters as new markers of functional iron deficiency in haemodialysis: sensitivity and specificity. Nephrol Dial Transplant 2007, 22:1156-1162.
58. Tessitore N., Solero G.P., Lippi G., et al. The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythropoietin. Nephrol Dial Transplant 2001, 16:1416-1423.
59. Mitsuiki K., Harada A., Miyata Y. Assessment of iron deficiency in chronic hemodialysis patients: investigation of cutoff values for reticulocyte hemoglobin content. Clin Exp Nephrol 2003, 7:52-57.
60. Waldvogel-Abramovski S., Waeber G., Gassner C., et al. Iron and transfusion medicine. Blood Rev 2014, 27:289-295.
61. Mast A.E., Foster T.M., Pinder H.L., et al. Behavioral, biochemical, and genetic analysis of iron metabolism in high-intensity blood donors. Transfusion 2008, 48(10):2197-2204.
62. Mast A.E., Schlumpf K.S., Wright D.J., et al. Demographic correlates of low hemoglobin deferral among prospective whole blood donors. Transfusion 2010. Haematol 1993, 85(4):787-798.
63. Feder J.N., Gnirke A., Thomas W., et al. Anovel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996, 13(4):399-408.
64. US Food and Drug Administration Guidance for Industry: variances for blood collection from individuals with hereditary hemochromatosis. Available at: . Accessed December 08, 2014. http://www.fda.gov/.../guidancecomplianceregulatoryinformation/guidances/blood/ucm076719.htm%20-%2048k%20-%202014-06-05.
65. Beutler E., Felitti V., Gelbart T., et al. Haematological effects of the C282Y HFE mutation in homozygous and heterozygous states among subjects of northern and southern European ancestry. Br J Haematol 2003, 120:887-893.
66. Adams P.C., Reboussin D.M., Barton J.C., et al. Hemochromatosis and iron-overload screening in a racially diverse population. NEngl J Med 2005, 352(17):1769-1778.
67. Mast A.E., Lee T.H., Schlumpf K.S., NHLBI Retrovirus Epidemiology Donor Study-II (RES-II), et al. The impact of HFE mutations on hemoglobin and iron status in individuals undergoing repeated iron loss through blood donation. Br J Haematol 2012, 156:388-401.
68. Lee P.L., Halloran C., Trevino R., et al. Human transferrin G277S mutation for iron deficiency anemia. Br J Haematol 2001, 115:329-333.
69. Nemeth E., Ganz T. Regulation of iron metabolism by hepcidin. Annu Rev Nutr 2006, 26:323-342.
70. Ganesh S.K., Zakai N.A., van Rooij F.J., et al. Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium. Nat Genet 2009, 41(11):1191-1198.
71. Du X., She E., Gelbart T., et al. The serine protease TMPRSS6 is required to sense iron deficiency. Science 2008, 320:1088-1092.
72. Chambers J.C., Zhang W., Li Y., et al. Genome-wide association study identifies variants in TMPRSS6 associated with hemoglobin levels. Nat Genet 2009, 41(11):1170-1172.
73. Benyamin B., Ferreira M.A., Willemsen G., et al. Common variants in TMPRSS6 are associated with iron status and erythrocyte volume. Nat Genet 2009, 41(11):1173-1175.
74. Mast AE, Langer JC, Bialkowski W, etal. The TMPRSS6 Ala736 Val polymorphism is associated with decreased hemoglobin and iron status in females undergoing repeated phlebotomy. Available at: . Accessed December 08, 2014. https://ash.confex.com/ash/2013/webprogram/Paper58169.html.
75. Kleinman S., Busch M.P., Murphy E.L., et al. The National Heart, Lung, and Blood Institute Recipient Epidemiology and Donor Evaluation Study (REDS-III): a research program striving to improve blood donor and transfusion recipient outcomes. Transfusion 2014, 54(3 Pt 2):942-955. 10.1111/trf.12468.